AbbVie concludes acquisition of ImmunoGen Ruchika Sharma14 Feb 2024 4:36 PM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition,...
AbbVie unveils Produodopa for Advanced Parkinson's Disease in EU Ruchika Sharma14 Jan 2024 1:00 PM ISTNorth Chicago, III.: AbbVie has announced the launch of PRODUODOPA (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced...
AbbVie, Umoja Biopharma collaborate to develop Novel In-Situ CAR-T Cell Therapies Ruchika Sharma8 Jan 2024 10:00 AM ISTNorth Chicago: AbbVie, and Umoja Biopharma, an early clinical-stage biotechnology company, have announced two exclusive option and license...
Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit Ruchika Sharma5 Jan 2024 4:15 PM ISTUnited States: A federal judge on Wednesday said Botox maker AbbVie's Allergan unit can move ahead with its lawsuit accusing Revance...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
AbbVie to focus on smaller deals after buying spree Ruchika Sharma9 Dec 2023 2:30 PM ISTAbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
Boehringer unveils 81 percent discounted biosimilar of AbbVie Humira Ruchika Sharma4 Oct 2023 3:30 PM ISTUntil recently, Humira was the world's biggest-selling prescription drug. It had sales of USD 21.2 billion in 2022.
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
AbbVie gets European Commission nod for Aquipta for prophylaxis of migraine in adults Ruchika Sharma20 Aug 2023 3:00 PM ISTNorth Chicago: AbbVie has announced that the European Commission has approved AQUIPTA (atogepant) for the prophylaxis of migraine in adults...
Lupin receives over Rs 205 crore from AbbVie for meeting key product development milestone Ruchika Sharma30 Jun 2023 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue ...
Coherus resolves part of dispute with AbbVie over Humira biosimilar Ruchika Sharma17 Jun 2023 11:00 AM ISTCoherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as the two fight over the terms of launching a...
